AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Business Wire
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2025, which ended August 31, 2024.Fiscal Year 2025 First Quarter Highlights Quarter EndedAugust 31, 2024Pro Forma* YoY GrowthNet Sales$67.5 million1.1%Med Tech Net Sales$28.0 million8.7%Med Device Net Sales$39.5 million(3.6)%GAAP gross margin of 54.4%GAAP loss per share of $0.31Adjusted loss per share of $0.11Submitted for FDA 510(k) clearance for Prostate Tissue indication for NanoKnifeReceived CE Mark Approval in Europe for the Auryon SystemInitiated RECOVER-AV Clinical Trial in Europe for AlphaVac*Pro forma results exclude the Dialysis and BioSentry businesses divested in June 2023 and the PICC and Midline product portfolios divested in Fe
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- CAH Stock Gains on the Launch of Kendall SmartFlow Compression System [Yahoo! Finance]Yahoo! Finance
- Photomedicine Devices and Technologies (Dermatology, Wound Healing Pain Management, Optical Diagnostics, Oncology) Market Size, Share and Trends Analysis Report 2024-2030 [Yahoo! Finance]Yahoo! Finance
- INBS Stock Declines Despite Positive Results of Pharmacokinetic Study [Yahoo! Finance]Yahoo! Finance
- SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments [Yahoo! Finance]Yahoo! Finance
- SYK Stock Rises Following the Launch of Next Generation SurgiCount+ [Yahoo! Finance]Yahoo! Finance
ANGO
Earnings
- 10/3/24 - Miss
ANGO
Sec Filings
- 11/15/24 - Form 8-K
- 11/8/24 - Form SC
- 10/23/24 - Form SC
- ANGO's page on the SEC website